	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	2.93	4.37	7.60	-33.0%	-61.4%
Operating Profit Qtr	-3.32	-6.58	1.31	49.5%	-353.4%
Net Profit Qtr	-3.43	-4.11	0.95	16.5%	-461.1%
Earning Per Share Adjusted latest Qtr	-3.39	-4.07	0.94	16.7%	-460.6%

* Consolidated data

Detailed Results

Decipher Labs Ltd.

14 Aug 2025, 06:35PM

10.81

-0.83%

Board Meeting

Decipher Labs Ltd - 524752 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Outcome of the Board meeting held on 14.08.2025

pdf

Decipher Labs Ltd.

12 Aug 2025

10.81

-0.83%

Company Update

Decipher Labs Ltd - 524752 - Disclosure As Per Regulation 30 Of SEBI Listing Regulations, 2015

BSE India

Disclosure as per Regulation 30 of SEBI Listing Regulations, 2015.

pdf

Decipher Labs Ltd.

11 Aug 2025

10.81

-0.83%

Board Meeting

Decipher Labs Ltd - 524752 - Board Meeting Intimation for Considering The Un-Audited Financial Results (Standalone …

BSE India

Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve inter alia, the following: Un-audited Financial results (Standalone and Consolidated) for the quarter ended June 30, 2025; Limited Review Report (Standalone and Consolidated) for the quarter ended June 30, 2025 and any other business with the permission of the Chair.

pdf

Decipher Labs Ltd.

15 Jul 2025, 06:18PM

10.81

-0.83%

Company Update

Decipher Labs Ltd - 524752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

pdf

Decipher Labs Ltd.

26 Jun 2025

10.81

-0.83%

SAST

Decipher Labs Ltd - 524752 - Closure of Trading Window

BSE India

Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015.

pdf

Decipher Labs Ltd.

30 May 2025

10.81

-0.83%

Board Meeting

Decipher Labs Ltd - 524752 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Outcome of the Board Meeting held on 30.05.2025

pdf

Decipher Labs Ltd.

27 May 2025

10.81

-0.83%

Board Meeting

Decipher Labs Ltd - 524752 - Board Meeting Intimation for Audited Financial Results And Audit Report …

BSE India

Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Audited Financial results (Standalone and Consolidated) for the quarter and year ended March 31, 2025. 2. Audit Report (Standalone and Consolidated) for the year ended March 31, 2025. 3. Any other business with the permission of the Chair.

pdf

Decipher Labs Ltd.

30 Apr 2025

10.81

-0.83%

Corp. Note

Decipher Labs Ltd - 524752 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Decipher Labs Ltd 2 CIN NO. L24230TG1986PLC006781 3 Report filed for FY 2024-2025 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2024-25, FY 2025-26 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) NA 8Quantum of (d), which has been met from (c)(e)* NA 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* NA Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2024-25, FY 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Ms Preeti SinghDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Mrs Sonam Jalan Designation : -CFO Date: 30/04/2025

pdf

Is Combat Drugs Ltd. worth buying?

56 Votes:

Buy 64.29%

Sell 17.86%

Hold 17.86%